Vivos Therapeutics, Inc. VVOS
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.48M | -7.68M | -6.89M | -5.40M | -5.01M |
| Total Depreciation and Amortization | 511.00K | 454.00K | 442.00K | 384.00K | 306.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -60.00K | 736.00K | -113.00K | 55.00K | 342.00K |
| Change in Net Operating Assets | 1.88M | 482.00K | 2.75M | 799.00K | 871.00K |
| Cash from Operations | -3.15M | -6.01M | -3.81M | -4.16M | -3.49M |
| Capital Expenditure | -416.00K | -18.00K | -1.53M | 83.00K | -771.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -50.00K | 0.00 | -5.14M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -416.00K | -18.00K | -1.58M | 83.00K | -5.91M |
| Total Debt Issued | 1.63M | 1.40M | 1.45M | -417.00K | 9.64M |
| Total Debt Repaid | -828.00K | -420.00K | -11.00K | -17.00K | -- |
| Issuance of Common Stock | -- | 5.62M | 2.80M | 5.60M | 347.00K |
| Repurchase of Common Stock | -791.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | 1.11M | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.12M | -487.00K | 97.00K | -2.41M | 1.47M |
| Cash from Financing | 3.23M | 6.11M | 4.34M | 2.76M | 11.46M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -336.00K | 81.00K | -1.06M | -1.32M | 2.06M |